102 related articles for article (PubMed ID: 15618365)
41. Cellular magnetic resonance imaging: current status and future prospects.
Arbab AS; Liu W; Frank JA
Expert Rev Med Devices; 2006 Jul; 3(4):427-39. PubMed ID: 16866640
[TBL] [Abstract][Full Text] [Related]
42. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.
Bos C; Delmas Y; Desmoulière A; Solanilla A; Hauger O; Grosset C; Dubus I; Ivanovic Z; Rosenbaum J; Charbord P; Combe C; Bulte JW; Moonen CT; Ripoche J; Grenier N
Radiology; 2004 Dec; 233(3):781-9. PubMed ID: 15486216
[TBL] [Abstract][Full Text] [Related]
43. [Sentinel lymph node after intramammary injection of superparamagnetic iron oxide].
Ishiyama K; Sashi R; Katayose Y; Tomura N; Watarai J; Narita K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):744-6. PubMed ID: 12508494
[TBL] [Abstract][Full Text] [Related]
44. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
Cyrus T; Winter PM; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):705-15. PubMed ID: 16076280
[TBL] [Abstract][Full Text] [Related]
45. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
Weissleder R; Lee AS; Fischman AJ; Reimer P; Shen T; Wilkinson R; Callahan RJ; Brady TJ
Radiology; 1991 Oct; 181(1):245-9. PubMed ID: 1887040
[TBL] [Abstract][Full Text] [Related]
46. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
47. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging.
Bulte JW; Arbab AS; Douglas T; Frank JA
Methods Enzymol; 2004; 386():275-99. PubMed ID: 15120257
[No Abstract] [Full Text] [Related]
48. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance imaging using hemagglutinating virus of Japan-envelope vector successfully detects localization of intra-cardially administered microglia in normal mouse brain.
Song Y; Morikawa S; Morita M; Inubushi T; Takada T; Torii R; Tooyama I
Neurosci Lett; 2006 Feb; 395(1):42-5. PubMed ID: 16298480
[TBL] [Abstract][Full Text] [Related]
50. Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering.
Koenig SH; Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Spiller M
Acad Radiol; 2002 May; 9 Suppl 1():S5-10. PubMed ID: 12019893
[No Abstract] [Full Text] [Related]
51. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
Clément O; Siauve N; Cuénod CA; Frija G
Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of acute heart transplant rejection can be visualized by cellular and functional cardiac magnetic resonance.
Epstein FH
JACC Cardiovasc Imaging; 2009 Jun; 2(6):742-3. PubMed ID: 19520345
[No Abstract] [Full Text] [Related]
53. Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging.
Zelivyanskaya ML; Nelson JA; Poluektova L; Uberti M; Mellon M; Gendelman HE; Boska MD
J Neurosci Res; 2003 Aug; 73(3):284-95. PubMed ID: 12868062
[TBL] [Abstract][Full Text] [Related]
54. Utility of NC100150 injection in cardiac MRI.
Johansson LO; Bjerner T; Bjornerud A; Ahlstrom H; Tarlo KS; Lorenz CH
Acad Radiol; 2002 May; 9 Suppl 1():S79-81. PubMed ID: 12019903
[No Abstract] [Full Text] [Related]
55. Splenic magnetic resonance imaging using particulate agents.
Small WC; Nelson RC; Sherbourne GM; Bernardino ME
Invest Radiol; 1994 Jun; 29 Suppl 2():S12-4. PubMed ID: 7928204
[No Abstract] [Full Text] [Related]
56. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles.
Elias A; Tsourkas A
Hematology Am Soc Hematol Educ Program; 2009; ():720-6. PubMed ID: 20008258
[TBL] [Abstract][Full Text] [Related]
57. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles.
Bulte JW; Hoekstra Y; Kamman RL; Magin RL; Webb AG; Briggs RW; Go KG; Hulstaert CE; Miltenyi S; The TH
Magn Reson Med; 1992 May; 25(1):148-57. PubMed ID: 1375703
[TBL] [Abstract][Full Text] [Related]
58. Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T.
Rose SE; Janke AL; Strudwick MW; McMahon KL; Chalk JB; Snyder P; De zubicaray GI
Magn Reson Med; 2006 Jan; 55(1):9-15. PubMed ID: 16342159
[TBL] [Abstract][Full Text] [Related]
59. The potential value of iron oxide nanoparticles in brain tumor treatment.
Gutin PH
AJNR Am J Neuroradiol; 2002 Apr; 23(4):505. PubMed ID: 11950633
[No Abstract] [Full Text] [Related]
60. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
Frank JA; Zywicke H; Jordan EK; Mitchell J; Lewis BK; Miller B; Bryant LH; Bulte JW
Acad Radiol; 2002 Aug; 9 Suppl 2():S484-7. PubMed ID: 12188316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
